CardieX Ltd. engages in the design, manufacture, and marketing of medical devices which is used for cardiovascular management. It operates through the following geographical segments: Americas, Europe, and Asia Pacific. The Americas segment is comprised of global pharmaceutical trials business. The Europe segment consist of Middle East and Africa. The Asia Pacific segment involves Asia, Australia, and New Zealand. The company was founded by Ross Harricks and Michael O'Rourke in 1993 and is headquartered in Sydney, Australia.